Nu Skin Enterprises Inc. announced its financial results for the second quarter of 2025. Revenue fell 12.1% year-over-year to $386.1 million. Year-over-year, gross margin showed a slight improvement from 76.1% to 77.5% for Nu Skin business. Overall, however, gross margin fell almost 2% year-over-year. Customer numbers and paid affiliates fell 14% and 16% respectively to 771,407 and 130,799, while sales leader numbers fell 23% to 29,593.
Other income resulted in a loss of $0.8 million compared to an income of $0.6 million in Q2 2024. EPS was $0.43.
The company stated that it was “encouraged by the positive results” of its ongoing effort to improve overall profitability and its resulting strengthened balance sheet, and reached a positive net cash position ahead of schedule for the first time in more than four years.
For 2025, Nu Skin now projects revenue of $1.48 billion to $1.55 billion and earnings per share of $3.05 to $3.25 with adjusted EPS of $1.15 to $1.35. For the third quarter, the company projects revenue between $360 million and $390 million, with earnings per share in the range of $0.25 to $0.35.
“We are pleased with our solid performance in the second quarter including our efforts to drive revenue at the high end of our guidance and significantly exceeding our forecast for earnings per share,” said Ryan Napierski, Nu Skin President and CEO. “We are also pleased with our ongoing operational optimization efforts resulting in 8% operating margin despite top-line pressures on the business. Our Rhyz Manufacturing segment continues to perform well with 17% year-over-year revenue growth. We also made significant progress during the quarter in building sales leader engagement and alignment for our key initiatives for late 2025 and 2026. We are on schedule for a mid-Q4 limited preview of our Prysm iO intelligent wellness device, the next innovation in our line of the world’s best-selling beauty and wellness device systems. We believe this AI-powered wellness assessment device will stimulate growth in our nutritional supplements business by providing personalized product recommendations and subscriptions to drive customer lifetime value. Additionally, leveraging success principles for developing markets gleaned from Latin America, where we had 107% year-over-year revenue growth, we are on track with our plans for Q4 market pre-opening activities in India with a formal launch anticipated for mid-2026. We remain confident in our strategy going forward to return to growth and drive shareholder value.”
